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ABSTRACT
Background. We studied the effects of a 
parallel phenylephrine infusion during 
bispectral index guided anaesthesia in-
duction with propofol on  haemodynamic 
parameters. We hypothesised that mean ar-
terial pressure and cardiac index would be 
better maintained in the group of patients 
receiving the phenylephrine infusion dur-
ing induction.
Methods. We studied ASA I-III patients 
scheduled for oncological abdominal sur-
gery. Forty patients randomly received ei-
ther a 0.9% NaCl or a phenylephrine (0.5 
μg/kg/min) infusion during the induction 
of anaesthesia with propofol to a bispectral 
index value of 60. Mean arterial pressure, 
stroke volume index and systemic vascular 
resistance index were recorded, starting at 
one minute before induction for 20 min-
utes, at one-minute intervals.
Results. After induction of anaesthesia 
before intubation mean arterial pressure 
and stroke volume index decreased sig-
nificantly compared to baseline in both 
groups, while the systemic vascular resist-
ance index increased slightly. At the end 
of measurements, mean arterial pressure 
(66 ± 11 vs. 94 ± 14 mmHg; 0.9% NaCl vs. 
phenylephrine group p<0.01) and stroke 
volume index (34.2 ± 9.1 vs. 44.0 ± 9.7 ml/
m2; 0.9% NaCl vs. phenylephrine group 
p<0.01) were lower in both groups in com-
parison to baseline values, but were better 
maintained in the phenylephrine group, 
whereas systemic vascular resistance index 
was higher than at  baseline (2308 ± 656 vs. 
3198 ± 825 dynes s/cm5/m2; 0.9% NaCl vs. 
phenylephrine group p<0.01) with signifi-
cant differences between  groups. 
Conclusion. Our study shows that  a con-
tinuous phenylephrine infusion  can atten-
uate the drop  in mean arterial pressure and 
stroke volume index during anaesthesia 
induction with propofol.
Key words: anaesthetics, propofol,  moni-
toring, depth of anaesthesia, consciousness 
monitors, bispectral index, sympathetic 
nervous system, phenylephrine, measure-
ment techniques, cardiac output
INTRODUCTION 
Maintaining haemodynamic stability dur-
ing induction and maintenance of anaes-
thesia is an important task for the anaes-
thesiologist. A recent meta-analysis has 
shown that propofol-based anaesthesia has 
no detrimental effect on survival. (1) How-
ever, anaesthesia induction with propofol is 
usually associated with a decrease in mean 
arterial pressure (MAP) and cardiac in-
dex (CI) after administration of the drug. 
(2) Various approaches to addressing this 
problem have been described in the litera-
ture, ranging from the use of different in-
travenous anaesthetic agents, (3) the use of 
titration to individualize the dosage of the 
induction agent with the use of bispectral 
index (BIS, Covidien, USA) guidance, (4) 
use of different opioids in different dosages 
(5,6) and using drugs affecting the stress re-
sponse before induction. (7)
Phenylephrine is a vasoconstrictor acting 
on both venous and arteriolar vascular 
beds thereby increasing both venous tone 
and systemic vascular resistance index 
(SVRI) and CI. (8) It is commonly used 
to treat hypotension during general and 
regional anaesthesia. (9,10) However, if 
we aim to maintain haemodynamic stabil-
ity during induction of anaesthesia with 
drugs known to cause haemodynamic 
compromise, especially in high risk elderly 
patients, preventing hypotension might be 
the preferred approach rather than simply 
treating the unwanted event. In the lit-
erature we found no study evaluating the 
haemodynamic effects of a continuous in-
fusion of phenylephrine during induction 
of general anaesthesia with propofol, al-
though such an approach has been studied 
in parturients receiving spinal anaesthesia 
for caesarean section. (11,12)
Due to the vasoconstrictor effects of phe-
nylephrine, we hypothesised that MAP and 
CI would be better maintained in the group 
of patients receiving a continuous phenyle-
phrine infusion during anaesthesia induc-
tion with propofol. The aim of our study 
was to evaluate the effect of a continuous 
phenylephrine infusion on maintenance 
of haemodynamic parameters during 
BIS guided induction of anaesthesia with 
propofol in a double blind randomized 
controlled trial. MAP was taken as the pri-
mary outcome variable and CI, stroke vol-
ume index (SVI), SVRI and heart rate (HR) 
were taken as secondary outcome variables.
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MATERIALS AND METHODS
Ethical approval for this study was provid-
ed by the National Medical Ethics Com-
mittee of Slovenia (Ref.: 229/09/13). The 
study was registered at ISRCTNregistry 
(www.isrctn.com): ISRCTN81365561. We 
included 50 ASA I-III patients scheduled 
for oncological abdominal surgery. Writ-
ten informed consent was obtained from 
each patient. 
Exclusion criteria were: chronic alcohol-
ism, intravenous drug use, body mass in-
dex >30, anticipated difficult intubation 
(Mallampati 3 and 4), serum creatinine > 
120 μmol/l, valvular heart disease, left ven-
tricular ejection fraction < 30%, systolic 
pressure higher than 160 and/or diastolic 
95 mmHg at the beginning of measure-
ments. 
All patients were fasted overnight, had the 
same bowel cleansing procedure, and took 
their regular medication on the morning 
of  surgery, except angiotensin-converting-
enzyme inhibitors. The patients were pre-
medicated with midazolam (0.1± 0.02 mg/
kg), orally, one hour before surgery. Upon 
arrival, a 16G i.v. line was inserted and an 
infusion of Lactated Ringers’ solution, 10 
ml/kg was administered. A radial arterial 
line for arterial pressure measurements 
and a LiDCOrapid monitor for measur-
ing CI (LiDCO Cardiac Sensor Systems, 
Cambridge, UK) were attached. The BIS 
electrodes were placed on the patient’s 
forehead and connected with the BIS – 
monitor. 
Patients were randomly assigned to the 
treatment and control group with respect 
to the drug infused during and after the 
induction of anaesthesia. Sealed envelopes 
prepared by the primary investigator were 
used for randomisation. The phenyle-
phrine group received an infusion of phe-
nylephrine 0.5 μg/kg/min starting at the 
same time as the infusion of propofol and 
running till the end of measurements.In 
the 0.9% NaCl group, an infusion of 0.9% 
NaCl ran during the same period. The in-
fusion pumps (Alaris, Cardinal Health, 
Ireland) were prepared independent of the 
investigators by a nurse in the recovery 
room.
The study protocol is shown in Figure 1. 
One minute after  baseline haemodynamic 
measurements were taken, fentanyl (Fen-
tanyl, Janssen-Cilag Pharma, Belgium) 
3 μg/kg was administered. Two minutes 
after fentanyl administration, an infusion 
of propofol (Propoven Fresenius 1%, Fre-
senius Kabi, Bad Homburg, Germany) 0.5 
mg/kg/min was started. Parallel with the 
propofol infusion, we started  the infusion 
of phenylephrine or 0.9% NaCl. At the loss 
of the palpebral reflex, rocuronium 0.6 
mg/kg was given i.v. When the BIS value 
reached 60, the infusion of propofol was 
stopped and the dose of propofol recorded. 
Laryngoscopy commenced when BIS was 
below 50. After tracheal intubation, the pa-
tient’s lungs were ventilated (Dräger-Pri-
mus, Germany) with oxygen and air (1:1) 
and sevoflurane, up to 1.5 vol%, which 
was titrated to maintain the BIS values 
between 40 and 60. MAP, CI, HR and BIS 
measurements were recorded pre-fentanyl 
and at one minute intervals for 20 minutes. 
Data were stored in an IBM-compatible 
computer. SVRI was calculated as follows: 
SVRI=MAP/CI*80. SVI was calculated as 
follows: SVI=1000*CI/HR. End-tidal CO2 
(etCO2) and end-tidal sevoflurane (etSevo) 
were measured every 3 minutes after intu-
bation. 
Hypotension (MAP≤55 mmHg) was treat-
ed with phenylephrine 50 μg i.v. boluses 
until resolved. 
Hypertension (MAP≥100 mmHg) was 
treated by stopping the infusion of the 
study solution. If hypertension persisted, 
it was treated with fentanyl 1 μg/kg- maxi-
mum of three doses- and afterwards with a 
nitro-glycerine infusion (10-100 μg/min). 
Bradycardia (HR≤40 min-1) was treated 
with atropine 0.3 mg i.v., up to three doses, 
and afterwards with boluses of ephedrine 
5 mg i.v. Tachycardia (HR≥90 min-1) was 
treated with fentanyl 1 μg/kg, up to three 
times.
Data were analysed with  IBM SPSS Sta-
tistics 18 statistical software. Data were 
tested for normality using Kolmogorov-
Smirnov test. Patients’ characteristics and 
baseline values were compared using a t 
test for independent samples and χ2 where 
appropriate. ANOVA for repeated meas-
urements with Greenhouse-Geiser cor-
rection was used to compare the changes 
in haemodynamic parameters over time 
and between the two treatment groups. 
In adition, t test for independent samples 
was performed to compare the haemody-
namic effects between the two groups, and 
the t test for paired samples to compare 
haemodynamic data at baseline, before 
intubation, after intubation and at the end 
of measurements. To account for multiple 
comparisons P < 0.01 was considered sta-
tistically significant. 
Sample size calculation to detect a differ-
ence in MAP of 20 mmHg (SD 17 mmHg) 
among treatment groups with a probability 
level of 0.01 and power of 0.80 yielded a 
sample size of 16 patients for each treat-
ment group.
RESULTS
We randomized 50 patients. Ten patients 
were excluded from analysis due to tech-
nical problems with monitors and due to 
increased MAP at the beginning of meas-
urements. Therefore, 40 patients were in-
cluded in the analysis. The CONSORT 
Flow Diagram is shown in Figure 2. 
No significant differences between the 
two groups with respect to patient char-
acteristics, diagnoses (Table 1) and base-
line haemodynamic measurements (Ta-
ble 2) were noticed. The mean dose (SD) 
of propofol (89.8 ± 20.5 vs. 96.7 ± 35.9 
mg; 0.9% NaCl vs. phenylephrine group; 
p=0.23; t test independent samples), the 
time until the loss of palpebral reflex (297 
  33 vs. 301   34 s; 0.9% NaCl vs. phenyle-
phrine group; p=0.75; t test independ-
ent samples) and the time until tracheal 
intubation (420 ± 41 vs. 430 ± 52 s; 0.9% 
NaCl vs. phenylephrine group; p=0.49; t 
test independent samples) also showed no 
significant differences between the groups.
Haemodynamic data measured during the 
study for both study groups are shown in 
Table 2. In Figure 3, the percent of changes 
from baseline value during 20 minutes of 
measurements are shown. There were no 
significant differences between the two 
groups with respect to MAP, CI, SVRI, HR 
and stroke volume index (SVI) comparing 
the baseline values at T1 (Table 2). 
As shown with ANOVA for repeated meas-
urements  (Table 2, Figure 3) CI, MAP, SVI 
and HR decreased significantly over time 
and SVRI increased significantly. MAP, 
SVI and SVRI were significanty higher in 
the phenylephrine group compared to the 
0.9% NaCl group. CI was higher (p=0.030) 
and HR was lower (p=0.044) in the phe-
nylephrine group and these differences 
were approaching statistical significance.
A detailed analysis of changes over time 
reveals that after induction of anaesthesia 
immediately before intubation (T3-T6) 
MAP, CI, and SVI decreased significantly 
compared to baseline in both groups, while 
the SVRI slightly increased (Table 2, Figure 
3). After induction of anaesthesia immedi-
ately before intubation (T3-T6) HR also 
decreased, but the changes were significant 
only in NaCl group (Table 2, Figure 3).
After intubation, a transient increase in 
MAP was seen in both groups (T8) but 
values were still below  baseline. MAP was 
significantly lower in the 0.9% NaCl group 
compared to the phenylephrine group in 
the period between3 minutes after intuba-
tion until the end of measurements (T10-
T20), but was significantly lower than 
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Table 1. Patient characteristics, primary and secondary diagnosis and medication used in patients receiving 0.9% NaCl or phenylephrine 
infusion during anaesthesia induction with propofol. 
0.9% NaCl (n=21) Phenylephrine  (N=19) p
Age (yr) 62.2 ± 9.7 66.6 ± 8.5 0.14
Gender (m/f)a 14/7 (67%/33%) 14/5 (74%/26%) 0.74
Height (cm) 170.8 ± 7.2 171.6 ± 7.3 0.75
Weight (kg) 76.3 ± 10.7 80.2 ± 10.3 0.25
Primary diagnosisa Colorectal carcinoma
Gastric carcinoma
Liver metastasis


































































Thyroid hormone replacement therapy 0 (0%) 0 (0%) -
Values are mean ± SD (t test independent samples)
a = values are number of cases (percent) (χ2 test)
ACEI, angiotensin-converting-enzyme  inhibitors; COPD, chronic obstructive pulmonary disease; TIA, transitory ischaemic attack. 
Table 2. Heart rate (HR), Mean Arterial Pressure (MAP), Cardiac Index (CI), Systemic Vascular Resistance Index (SVRI) and Stroke 
Volume Index (SVI) values are represented at different time points.  
Time 
(min)










T1 100 ± 14 104 ± 13 3.82 ± 1.20 3.46 ± 1.09 52.3 ± 12.3 52.4 ± 10.2 72 ± 11 66 ± 15 2107 ± 627 2409 ± 647
T3 97 ± 17 100 ± 14 3.70 ± 1.28 3.27 ± 1.09† 51.8 ± 12.4 51.4 ± 10.3 70 ± 14 64 ± 16† 2124 ± 616 2482 ± 702
T6 84 ± 12† 90 ± 19† 3.09 ± 0.91† 2.68 ± 0.88† 45.3 ± 11.4† 44.1 ± 10.1† 68 ± 7† 61 ± 12 2140 ± 592 2596 ± 668
T8 87 ± 23 97 ± 20 3.23± 1.30† 2.67 ± 0.64† 42.2 ± 13.5† 43.4 ± 9.6† 75 ± 11* 63 ± 12* 2124 ± 477* 2796 ± 686*†
T10 76 ± 17*† 94 ± 20*† 2.88 ± 1.22† 2.50 ± 0.75† 39.4 ± 13.3† 43.8 ± 9.9† 72 ± 12* 58 ± 13*† 2131 ± 650* 2902 ± 667*†
T15 64 ± 10*† 91 ± 13*† 2.27 ± 0.88† 2.27 ± 0.52† 35 ± 9.9*† 43.9 ± 8.9*† 64 ± 10*† 52 ± 9*† 2217 ± 685* 3064 ± 605*†




df=3.6   F=9    p=0.000
df=3.6   F=9    p=0.000
df=3.2   F=59   p=0.000
df=3.6   F=3     p=0.030
df=3.2   F=76   p=0.000
df=3.2   F=14   p=0.000
df=3.5   F=23    p=0.000
df=3.5   F=2.6   p=0.044
df=3.5   F=2.6   p=0.044
df=3.3   F=6.6   p=0,000
Data are mean ± SD. 
* p<0.01 between  groups (t test for inde-
pendent samples)  
T1 = baseline  (1st minute)  
T3 = 3rd minute of measurements
† p<0.01 with respect to baseline (t test for 
paired samples)  
T6 = 6th minute - before Intubation 
T8 = 8th minute - after Intubation 
T10 = 10th minute of measurements
P = phenylephrine group  
T15 = 15th minute of measurements
S = 0.9% saline group  
T20 = 20th minute of measurements
ANOVA = parameters for repeated meas-
ures ANOVA with a Greenhouse-Geisser 
correction for within (Time) and between 
(Group) group comparison
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baseline in both groups (Table 2, Figure 3). 
CI was significantly decreased after ETI 
and remained significantly decreased com-
pared to  baseline values in both groups 
until the end of measurements (T8-T20) 
(Table 2, Figure 3). The time course of the 
percent change in CI (Figure 3) shows that 
the parameter was better maintained in the 
phenylephrine group. 
SVI was significantly decreased after in-
tubation compared to  baseline values in 
both groups, but was significantly higher 
in the phenylephrine group compared to 
the 0.9% NaCl group at the end of meas-
urements (T15-T20) (Table 2, Figure 3).
SVRI remained significantly increased af-
ter intubation in the phenylephrine group 
(T8-T20), but slightly increased in the 
NaCl group reaching a statistically signifi-
cant difference at the end of measurements 
(T20) (Table 2, Figure 3). SVRI in the 
phenylephrine group was significantly in-
creased compared to the 0.9% NaCl group 
after intubation until the end of measure-
ments (T8-T20) (Ttable 2, Figure 3).
After intubation, HR transiently  signifi-
cantly increased (T8) in the 0.9% NaCl 
group more than in the phenylephrine 
group. After that, HR decreased sig-
nificantly in both groups until the end of 
measurements (T15-T20) After intuba-
tion, until the end of measurements,  HR 
was significantly decreased in the phenyle-
phrine group compared to the 0.9% NaCl 
group (T8-T20) (Table 2, Figure 3). 
After induction of anaesthesia, the BIS val-
ue decreased significantly in both groups 
with no differences between the groups 
(Figure 3). There were no significant dif-
ference between  groups after intubation 
regarding etCO2 and inspiratory and ex-
piratory etSevo.
Due to hypotension, five  patients in the 
0.9% NaCl group received one or more 
boluses of phenylephrine. No additional 
phenylephrine boluses were adminis-
tered in the phenylephrine group. Due to 
hypertension in three  patients in the P 
group, the infusion of phenylephrine was 
stopped. No additional fentanyl or nitro-
glycerine was given. Due to bradycardia, 
two patients in the P group received 0.3 mg 
of atropine. We did not observe any signs 
of ischaemia, ECG or ST-segment changes 
in any patient.
DISCUSSION
We studied the influence of a phenyle-
phrine infusion  on BIS guided induction 
in  general anaesthesia patients scheduled 
for major abdominal surgery. Our study 
showed that  MAP was better maintained 
after induction in patients receiving a 
phenylephrine infusion. The better main-
tenance of MAP was caused primarily by 
an increase in SVRI in the phenylephrine 
group; however, important differences be-
tween the groups in parameters defining 
CI (HR and SVI) were also measured. 
We used the BIS guided approach to ti-
trate  propofol during induction to a BIS 
value of 60, when the propofol infusion 
was stopped. The so called “hysteresis” of 
propofol  causes a further decrease of BIS 
after stopping the propofol infusion. (13) 
Since there is also a time delay of the BIS 
value on the display monitor (10-15 sec-
onds or even more), (14) after stopping the 
propofol infusion the BIS value continued 
to decrease until ETI was performed at a 
BIS value of approximately 50. With this 
approach we could decrease the dose of 
propofol well below the recommended 1.5-
2.5 mg/kg range (15) (in our study 89.8 ± 
20.5 mg in the 0.9% NaCl group and 96.7 ± 
35.9 mg in the phenylephrine group). We 
decided to use the above mentioned speed 
of propofol infusion on the basis of already 
described pharmacokinetics and pharma-
codynamics reported  in the literature (0.5 
and 0.75 mg/kg/min). (16-18)
The differences between the groups in 
Figure 1. Study protocol 
Figure 2. Flow diagram of the study
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nominal SVI and CI were measured with 
the LiDCORapid. Nominal values are de-
rived and estimated from a population 
based nomogram. (19,20)  However, in our 
study we were interested in trends of SVI 
and CI rather than the actual values. In 
addition, the LiDCORapid only requires a 
standard radial arterial line and uses pulse 
power analysis for the measurement of 
nominal SV. (21)
Phenylephrine is a potent vasoconstric-
tor acting predominantly on  1 receptors 
influencing both the venous and arterial 
vascular beds and exerts mild ionotropic 
effects only when administered at high 
concentrations. (8,22,23) The effect of phe-
nylephrine at dosages used in our study is 
on both venous and arteriolar vasocon-
striction with the latter demonstrated by 
an increase in SVRI, whilst at lower doses 
the effect may be predominantly on venous 
tone. The increase in SVRI was accompa-
nied by a higher MAP in the P group of 
patients. 
After propofol induction, nominal CI de-
creased to the same degree in both groups. 
This was caused by a significant decrease 
in SVI and HR. Several parameters in-
fluenced the decrease in CI in our study. 
Propofol venodilation decreases preload 
and SVI. (24) The mechanisms for veno-
dilation during general anaesthesia and 
its physiological consequences have been 
reviewed recently. (25) Additional param-
eters causing a decrease in preload and SVI 
are the addition of sevoflurane and posi-
tive pressure ventilation of the lungs after 
intubation. The main cause for the ten-
dency towards bradycardia in both groups 
was probably administration of the opioid 
(fentanyl) and after intubation the de-
crease in sympathetic tone. Nevertheless, 
all the changes mentioned above apply to 
the same extent to both groups of patients 
in our study.
However, important differences between 
the groups were measured in the extent of 
changes in parameters defining the nomi-
nal CI. After induction and intubation, 
SVI was significantly higher in the phe-
nylephrine group while  HR was signifi-
cantly lower in the phenylephrine group, 
in comparison to the 0.9% NaCl group. 
Baroreceptor reflex activation is probably 
one important reason for this difference. 
Since MAP was higher in the phenyle-
phrine group, this led to a decrease in HR 
thereby prolonging the filling period of 
the heart and increasing the SVI. Another 
reason for the higher SVI in the phenyle-
phrine group of patients is probably the 
vasoconstrictor effect of phenylephrine on 
the venous vascular bed, which has been 
reported in the literature. (22) In Figure 
2,  percent changes of haemodynamic 
parameters are shown. We can see that in 
the last 10 minutes of measurements the 
percent change CI is better maintained in 
the phenylephrine group of patients. Thus, 
the difference in SVI between  groups is 
actually higher than the difference in HR, 
which could probably be explained by the 
venoconstrictor effect of phenylephrine 
increasing the preload to the heart and 
increasing the SVI. A similar observation 
was reported  recently by Poterman and 
co-workers (26) while studying the effects 
of phenylephrine and norepinephrine on 
peripheral tissue oxygenation.
In the literature we found no studies evalu-
ating  haemodynamic changes during BIS 
guided induction of general anaesthesia 
with propofol with a parallel infusion of 
phenylephrine. Imran and co-workers 
(27) evaluated the effects of induction of 
anaesthesia with propofol (using a 2.5 mg/
kg dosage) combined with a bolus admin-
istration of either 0.9% NaCl or phenyle-
phrine 50 μg and 100 μg. Only a 100 μg 
dose effectively attenuated the hypoten-
sion during induction. BIS and CI were not 
measured in their study.
Additional phenylephrine boluses were 
given to five patients in the 0.9% NaCl 
group. In the phenylephrine group two 
patients needed atropine for treatment of 
bradycardia and in three patients the in-
fusion of the study solution was stopped 
due to hypertension. This confirms the 
clinical observation, that the dosage of 
phenylephrine infusion during induction 
should be individualized to the patient’s 
needs. The infusion rate (0.5 μg/kg/min) 
was based on the study by  Allen and co-
workers. (11) The authors evaluated four 
different infusion rates of phenylephrine 
for prevention of hypotension after spinal 
Figure 3.  Time course of the percent change in mean arterial pressure, cardiac index, stroke 
volume index, systemic vascular resistance, heart rate, absolute bispectral index value 
changes and repeated measures ANOVA data in patients receiving 0.9% NaCl or phenyle-
phrine infusion during anaesthesia induction with propofol (MAP = mean arterial pres-
sure, SVI = stroke volume index,  CI = cardiac index, HR = heart rate, SVRI = systemic 
vascular resistance, BIS = bispectral index; ANOVA = repeated measures ANOVA with a 
Greenhouse-Geisser correction parameters for within (Time) and between (Group) group 
comparison; * p<0.01 between the groups (t test for independent samples); ↑ = start of the 
induction, ↓ = tracheal intubation). 
Black solid and dashed lines show the mean values of the parameters in the population, and 
the error bars show the SD.
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anaesthesia for caesarean delivery. The in-
fusion rates of phenylephrine of 100 and 75 
μg/min were associated with an increased 
incidence of hypertension in comparison 
with the infusion rates 25 and 50 μg/min. 
The infusion rate of phenylephrine in our 
study was between the two lower recom-
mended dosages, but was obviously too 
high for three of our patients. However, 
prophylactic administration of phenyle-
phrine markedly reduces the fall in MAP 
at induction. Recent large scale restrospec-
tive studies, such as the study by  Walsh 
and co-workers (28), have shown that 
even very short periods of low MAP may 
be associated with poor outcome. So any 
degree of hypotension is best avoided and 
the phenylephrine infusion can be stopped 
any time in case of an exagerated effect.
Our study shows that we can attenuate the 
decrease in MAP during anaesthesia in-
duction with propofol by administering a 
continuous phenylephrine infusion during 
the induction period. The primary clini-
cal effect of the phenylephrine infusion at 
dosages used in our study is the increase 
in SVRI. Additional improvements in 
haemodynamics during induction of an-
esthesia with propofol might be achieved 
by starting a lower (0.25  g/kg/min), veno-
constricting dose of phenylephrine much 
earlier in the induction sequence, e.g., fol-
lowing insertion of the arterial line and 
obtaining baseline haemodynamic param-
eters. In addition, reducing the bradycard-
ic effects of fentanyl, by prophylactic use of 
anti-cholinergics, might better maintain 
heart rate and thus cardiac output. Such an 
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